De Rucci Healthy Sleep Co., Ltd.

SZSE:001323 Stock Report

Market Cap: CN¥14.6b

De Rucci Healthy Sleep Future Growth

Future criteria checks 1/6

De Rucci Healthy Sleep is forecast to grow earnings and revenue by 7.3% and 6.4% per annum respectively. EPS is expected to grow by 7.8% per annum. Return on equity is forecast to be 16.9% in 3 years.

Key information

7.3%

Earnings growth rate

7.8%

EPS growth rate

Consumer Durables earnings growth13.1%
Revenue growth rate6.4%
Future return on equity16.9%
Analyst coverage

Good

Last updated30 Jan 2025

Recent future growth updates

Recent updates

Here's Why We Think De Rucci Healthy Sleep (SZSE:001323) Is Well Worth Watching

Jan 10
Here's Why We Think De Rucci Healthy Sleep (SZSE:001323) Is Well Worth Watching

Here's What's Concerning About De Rucci Healthy Sleep's (SZSE:001323) Returns On Capital

Dec 05
Here's What's Concerning About De Rucci Healthy Sleep's (SZSE:001323) Returns On Capital

Here's Why De Rucci Healthy Sleep (SZSE:001323) Has Caught The Eye Of Investors

May 22
Here's Why De Rucci Healthy Sleep (SZSE:001323) Has Caught The Eye Of Investors

Statutory Profit Doesn't Reflect How Good De Rucci Healthy Sleep's (SZSE:001323) Earnings Are

May 03
Statutory Profit Doesn't Reflect How Good De Rucci Healthy Sleep's (SZSE:001323) Earnings Are

Is De Rucci Healthy Sleep (SZSE:001323) A Risky Investment?

Apr 30
Is De Rucci Healthy Sleep (SZSE:001323) A Risky Investment?

Investors Could Be Concerned With De Rucci Healthy Sleep's (SZSE:001323) Returns On Capital

Feb 28
Investors Could Be Concerned With De Rucci Healthy Sleep's (SZSE:001323) Returns On Capital

Earnings and Revenue Growth Forecasts

SZSE:001323 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,9001,008N/A1,2066
12/31/20256,368914N/A1,3077
12/31/20245,815829N/A8497
12/31/20235,851806N/A1,1467
9/30/20235,4658001,3731,838N/A
6/30/20235,4607561,2491,746N/A
3/31/20235,5256867881,304N/A
12/31/20225,81370926647N/A
9/30/20226,36370012693N/A
6/30/20226,424669105840N/A
3/31/20226,483674N/AN/AN/A
1/1/20226,481686226995N/A
12/31/20204,452536530986N/A
12/31/20193,862333574943N/A
12/31/20183,188216-153358N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 001323's forecast earnings growth (7.3% per year) is above the savings rate (2.8%).

Earnings vs Market: 001323's earnings (7.3% per year) are forecast to grow slower than the CN market (25% per year).

High Growth Earnings: 001323's earnings are forecast to grow, but not significantly.

Revenue vs Market: 001323's revenue (6.4% per year) is forecast to grow slower than the CN market (13.3% per year).

High Growth Revenue: 001323's revenue (6.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 001323's Return on Equity is forecast to be low in 3 years time (16.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/03 02:36
End of Day Share Price 2025/01/27 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

De Rucci Healthy Sleep Co., Ltd. is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bairu ChenChina Galaxy Securities Co., Ltd.
Zhuonan XuChina International Capital Corporation Limited
Junhao FanChina International Capital Corporation Limited